Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?

Archives of Gynecology and Obstetrics

Volumn 287, Issue 5, 2013, Pages 865-873

  Ghosh, Sanjib Kumar ^a   Raheja, Shashi ^a   Tuli, Anita ^a   Raghunandan, Chitra ^a   Agarwal, Sneh ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Early onset preeclampsia; Early second trimester; First trimester; Logistic regression analysis; Placental growth factor

Indexed keywords

BIOLOGICAL MARKER; PLACENTAL GROWTH FACTOR;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; PREECLAMPSIA; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; LOGISTIC MODELS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84876674983     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2662-2     Document Type: Article

References (43)

1. Pennings JL, Kuc S, Rodenburg W, Koster MP, Schielen PC, de Vries A (2011) Integrative data mining to identify novel candidate serum biomarkers for preeclampsia screening. Prenat Diagn 31(12):1153-1159
2. Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC (2011) Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 66(4):225-239
3. Crispi F, Dominguez C, Liurba E, Martin-Gallan P, Cabero L, Gratacos E (2006) Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 195:201-207 (Pubitemid 43927524)
4. Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E (2008) Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 31:303-309
5. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu K (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683 (Pubitemid 38364626)
6. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee KY, Goncalves LF (2004) Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol 190:1541-1547 (Pubitemid 39006187)
7. Andraweera PH, Dekker GA, Roberts CT (2012) The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update 18(4):436-457
8. Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH (2010) Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol 35(6):662-670
9. Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E (2010) Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 203(4): 383.e1-8
10. Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, Visser GH (2010) First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early onset preeclampsia. BJOG 117(11):1384-1389
11. Unal ER, Robinson CJ, Johnson DD, Chang EY (2007) Second-trimester angiogenic factors as biomarkers for future onset preeclampsia. Am J Obstet Gynecol 197(2): 211.e1-4
12. De Vivo A, Baveira G, Giordano D, Todarello G, Corrado F, D'anna R (2008) Endoglin, PlGF and sFlt-1 as markers for predicting preeclampsia. Acta Obstet Gynecol Scand 87(8):837-842
13. Diab AE, El-Behery MM, Ebraheim MA, Shehata AE (2008) Angiogenic factors for the prediction of preeclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 102(2):146-151
14. Lambert- Messeriian GM, Palomaki GE, Neveux LM, Chien E, Friedman A (2009) Early onset preeclampsia and second trimester serum markers. Prenat Diagn 29(12):1109-1117
15. Mishra D, Singh HP (2003) Kuppuswamy's socioeconomic status scale - a revision. Indian J Pediatr 70(3):273-274 (Pubitemid 36560159)
16. Davey DA, MacGillivray I (1988) The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892-898
17. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R (2000) Preeclampsia and fetal growth. Obstet Gynecol 96:950-955
18. MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533-538
19. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B (2003) The frequency and severity of placental findings in women with preeclampsia and gestational age dependent. Am J Obstet Gynecol 189:1173-1177 (Pubitemid 37373917)
20. Sebire NJ, Goldin RD, Regan L (2005) Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 25:117-118 (Pubitemid 43323022)
21. Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592-1594 (Pubitemid 40807500)
22. Rasmussen S, Irgens LM (2003) Fetal growth and body proportion in preeclampsia. Obstet Gynecol 101:575-583 (Pubitemid 36288501)
23. Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG (2004) Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond) 106:377-382 (Pubitemid 38553585)
24. Smith GC, Wear H (2009) The perinatal implications of angiogenic factors. Curr Opin Obstet Gynecol 21(2):111-116
25. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF (2007) Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 196(4):326.e1-326.e13 (Pubitemid 46497902)
26. Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E (2009) A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 22(11):1021-1038
27. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational- age neonate. J Matern Fetal Med 21(1):9-23
28. Wulff C, Wilson H, Dickson SE, Wiegand SJ, Fraser HM (2002) Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66:802-812 (Pubitemid 34193939)
29. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395 (Pubitemid 30208155)
30. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242-248
31. Pijnenborg R, Robertson WB, Brosens I, Dixon G (1981) Trophoblast invasion and the establishment of hemochorial placentation in man and laboratory animals. Placenta 2:71-91 (Pubitemid 11179363)
32. Gerretsen G, Huisjes HJ, Elema JD (1981) Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. BJOG 88:876-881 (Pubitemid 11018178)
33. Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M, Beckmann MW (2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 29:407-413 (Pubitemid 46632236)
34. Khaliq A, Dun KC, Jiang J, Shams M, Li XF (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor estimation: molecular evidence for "placental hypoxia' in intrauterine growth restriction. Lab Invest 79(2):151-170 (Pubitemid 29110646)
35. Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y (2004) Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145:4838-4845 (Pubitemid 39551100)
36. Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS (1997) Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18:657-665 (Pubitemid 27448423)
37. Gomez O, Figueras F, Martinez JM, Del Rio M, Palacio M, Eixarch E (2006) Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 28:802-808 (Pubitemid 44787466)
38. Kurdi W, Fayyad A, Thakur V, Harrington K (2004) Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon. Eur J Obstet Gynecol Reprod Biol 117:20-23 (Pubitemid 39335857)
39. Hafner E, Schuchter K, Metzenbauer M, Philipp K (2000) Uterine artery Doppler perfusion in the first and second pregnancies. Ultrasound Obstet Gynecol 16:625-629 (Pubitemid 32174702)
40. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184:1267-1272 (Pubitemid 32434285)
41. Erez O, Romero R, Espinoza J et al (2008) The change in concentrations of angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent of preeclampsia and SGA. J Matern Fetal Neonatal Med 21(5):279-287 (Pubitemid 351652513)
42. Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E (2011) Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 24(10):1187-1207
43. Ness RB, Roberts JM (1996) Heterogenous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175:1365-1370 (Pubitemid 26399006)